Last reviewed · How we verify
Dyspnea
Approved treatments
- Epipen · Pfizer Inc.
Epipen works by stimulating the alpha-1D adrenergic receptor to rapidly increase heart rate, blood pressure, and bronchodilation. - Bupivacaine Hydrochloride And Epinephrine · Pfizer Inc.
Epinephrine works by stimulating the alpha-1D adrenergic receptor to increase heart rate and blood pressure, and to constrict blood vessels. - Epinephrin · United States Naval Medical Center, San Diego
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Dyspnea patent landscape — cliff calendar, originator estates, attackable patents
- Dyspnea treatment landscape brief
- Dyspnea treatment updates RSS
Frequently asked questions about Dyspnea
What drugs treat Dyspnea?
Tracked treatments include Epipen, Bupivacaine Hydrochloride And Epinephrine, Epinephrin.
What is the treatment for Dyspnea?
Standard treatment for Dyspnea includes Epipen, Bupivacaine Hydrochloride And Epinephrine, Epinephrin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Dyspnea patent cliff · Dyspnea CI report
- Treatment: Epipen · Pfizer Inc.
- Treatment: Bupivacaine Hydrochloride And Epinephrine · Pfizer Inc.
- Treatment: Epinephrin · United States Naval Medical Center, San Diego
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing